Pharmesis International Ltd. (SGX:BFK)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.4150
+0.0200 (5.06%)
Last updated: Jun 23, 2026, 3:58 PM SGT
Market Cap13.16M +128.8%
Revenue (ttm)8.05M -35.3%
Net Income-790.93K
EPS-0.02
Shares Out 31.70M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,100
Open0.4100
Previous Close0.3950
Day's Range0.3800 - 0.4150
52-Week Range0.2000 - 0.5000
Beta-1.17
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About Pharmesis International

Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China. The company operates through three segments: Western drugs/TCH Procurement, TCM formulated drugs/IP Rental, and Distribution. It provides prescribed products and over-the-counter drugs. The company offers Anethole Trithione for the treatment of illness relating to the liver and ... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 1,096
Stock Exchange Singapore Exchange
Ticker Symbol BFK
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements